Clarus Defined Exit I, L.P.

Insider Reports History

Entity
Company
Location
101 Main Street, Suite 1210, Cambridge, MA
Signature
CLARUS DEFINED EXIT I, L.P., By: Clarus Ventures DE GP, L.P., its GP, By: Blackstone Clarus DE L.L.C., its GP, By: Blackstone Holdings II L.P., its sole member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, Senior Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clarus Defined Exit I, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. 10%+ Owner Common Stock 160K $2.72M $16.99 May 11, 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series A-1 Convertible Preferred Stock 0 May 11, 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 May 11, 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 May 11, 2021 Indirect

Insider Reports Filed by Clarus Defined Exit I, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TALS Talaris Therapeutics, Inc. May 11, 2021 33 $510K 4 May 13, 2021 10%+ Owner